Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610764200 on January 5, 2007

J. Biol. Chem., Vol. 282, Issue 10, 7723-7732, March 9, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/10/7723    most recent
M610764200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, H.-R.
Right arrow Articles by Elias, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, H.-R.
Right arrow Articles by Elias, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transforming Growth Factor (TGF)-beta1 Stimulates Pulmonary Fibrosis and Inflammation via a Bax-dependent, Bid-activated Pathway That Involves Matrix Metalloproteinase-12*Formula

Hye-Ryun Kang{ddagger}, Soo Jung Cho{ddagger}, Chun Geun Lee{ddagger}, Robert J. Homer§, and Jack A. Elias{ddagger}1

From the {ddagger}Section of Pulmonary and Critical Care Medicine and the §Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520

Fibrosis, apoptosis, and the exaggerated production of transforming growth factor (TGF)-beta1 are juxtaposed in a variety of pulmonary diseases including the interstitial lung diseases and asthma. In these disorders, the relationships between these responses are not well defined. In addition, the apoptosis pathways that contribute to these responses and the mechanism(s) of their contribution have not been described. We hypothesized that BH3 domain-only protein-induced apoptosis plays an important role in the pathogenesis of TGF-beta1-induced pulmonary responses. To test this hypothesis, we characterized the effects of transgenic TGF-beta1 in mice with wild type (WT) and null Bax loci. To investigate the mechanisms of Bax activation and its effector functions, we also compared the effects of TGF-beta1 in mice with WT and null Bid and matrix metalloproteinase (MMP)-12 loci, respectively. These studies demonstrate that TGF-beta1 is a potent stimulator of Bax, Bid, and MMP-12. The studies also demonstrate that Bax and Bid play key roles in the pathogenesis of TGF-beta1-induced inflammation, fibrosis, and apoptosis; that TGF-beta1 stimulates MMP-12, TIMP-1, and cathepsins and inhibits MMP-9 and p21 via Bax- and Bid-dependent mechanisms; and that TGF-beta1-stimulated pulmonary fibrosis is ameliorated in MMP-12-deficient animals. Finally, they demonstrate that Bax, Bid, and MMP-12 play similar roles in bleomycin-induced fibrosis, thereby highlighting the importance of this Bid-activated, Bax-mediated pathway and downstream MMP-12 in a variety of fibrogenic settings.


Received for publication, November 20, 2006 , and in revised form, January 4, 2007.

* These studies were supported in part by National Institutes of Health Grants HL-56389 (to J. A. E.), HL-064242 (to J. A. E.), HL-078744 (to J. A. E.), and HL-084225 (to C. G. L.) and the postdoctoral fellowship program of the Korea Science & Engineering Foundation (KOSEF). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1.

1 To whom correspondence should be addressed: Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT 06520-8057. Tel.: 203-737-4249; Fax: 203-785-3826; E-mail: jack.elias{at}yale.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Moodley, D. Atienza, U. Manuelpillai, C. S. Samuel, J. Tchongue, S. Ilancheran, R. Boyd, and A. Trounson
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
Am. J. Pathol., July 1, 2009; 175(1): 303 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Maret, C. Ruffie, S. Letuve, A. Phelep, O. Thibaudeau, J. Marchal, M. Pretolani, and A. Druilhe
A Role for Bid in Eosinophil Apoptosis and in Allergic Airway Reaction
J. Immunol., May 1, 2009; 182(9): 5740 - 5747.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros
Apoptosis in lung injury and fibrosis
Eur. Respir. J., December 1, 2008; 32(6): 1631 - 1638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A.-M. Pulichino, I-M. Wang, A. Caron, J. Mortimer, A. Auger, Y. Boie, J. A. Elias, A. Kartono, L. Xu, J. Menetski, et al.
Identification of Transforming Growth Factor {beta}1-Driven Genetic Programs of Acute Lung Fibrosis
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 324 - 336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement